You are here

SCAI 2017

Wednesday, May 10, 2017 to Saturday, May 13, 2017

Latest Headlines

A late-breaking study, presented May 12 at the Society of Cardiovascular Angiography and Interventions meeting in New Orleans, showed that factors related to individual patients—and not the specific type of valve used—determined 30-day outcomes for transcatheter aortic valve replacement (TAVR).

New research revealed at the Society for Cardiovascular Angiography and Interventions (SCAI) meeting in New Orleans last week showed that being a white man could yield better outcomes when it comes to undergoing a percutaneous coronary intervention (PCI) with a drug-eluting stent.

The May 12 late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions in New Orleans compared femoral and radial robotic percutaneous coronary intervention (PCI) procedures.

The Society for Cardiovascular Angiography and Interventions (SCAI) recently announced the late-breaking clinical trials sessions for the SCAI 2017 scientific sessions.